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Abstract
Background: Ricin (also called RCA-II or RCA60), one of the most potent toxins and documented bioweapons, is derived
from castor beans of Ricinus communis. Several in vitro methods have been designed for ricin detection in complex food
matrices in the event of intentional contamination. Recently, a novel Immuno-PCR (IPCR) assay was developed with a limit
of detection of 10 fg/ml in a buffer matrix and about 10-1000-fold greater sensitivity than other methods in various food
matrices.
Methods and Findings: In order to devise a better diagnostic test for ricin, the IPCR assay was adapted for the detection of
ricin in biological samples collected from mice after intoxication. The limit of detection in both mouse sera and feces was as
low as 1 pg/ml. Using the mouse intravenous (iv) model for ricin intoxication, a biphasic half-life of ricin, with a rapid t1/2a of
4 min and a slower t1/2b of 86 min were observed. The molecular biodistribution time for ricin following oral ingestion was
estimated using an antibody neutralization assay. Ricin was detected in the blood stream starting at approximately 6–7 h
post- oral intoxication. Whole animal histopathological analysis was performed on mice treated orally or systemically with
ricin. Severe lesions were observed in the pancreas, spleen and intestinal mesenteric lymph nodes, but no severe pathology
in other major organs was observed.
Conclusions: The determination of in vivo toxicokinetics and pathological effects of ricin following systemic and oral
intoxication provide a better understanding of the etiology of intoxication and will help in the future design of more
effective diagnostic and therapeutic methods.
Citation: He X, McMahon S, Henderson TD II, Griffey SM, Cheng LW (2010) Ricin Toxicokinetics and Its Sensitive Detection in Mouse Sera or Feces Using Immuno-
PCR. PLoS ONE 5(9): e12858. doi:10.1371/journal.pone.0012858
Editor: Immo A. Hansen, New Mexico State University, United States of America
Received June 20, 2010; Accepted August 23, 2010; Published September 22, 2010
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public
domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: This work was funded by the United States Department of Agriculture, Agricultural Research Service, National Program project NP108, CRIS 5325-
42000-043-00D, and United States Public Health Service Grant U54 AI065359 (to L.W.C.). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: luisa.cheng@ars.usda.gov
Introduction
Ricin is derived from the seeds of the castor plant Ricinus
communis, and comprises approximately 1% to 5% of the weight of
the castor bean mash that remains after oil extraction [1–3]. The
high toxicity and large quantities of raw materials readily available
to produce toxin are a major bio-terror concern [3–5]. In its crude
form, ricin is often found in association with a lectin, Ricinus
communis agglutinin (RCA-I or RCA120), which has hemaggluti-
nating activity but greatly reduced toxicity compared to ricin.
RCA-I is a tetramer containing two non-covalently bonded ricin-
like dimers. Ricin is a member of the Type II ribosome
inactivating proteins, known as dimeric or AB toxins, of which
shiga and shiga-like toxins are members [6]. The two ricin
polypeptide chains have molecular weights of 30 kDa (A) and
33 kDa (B), and are normally linked by a single disulfide bond.
The ricin A chain is a highly active N-glycosidase that initiates
depurination and cleavage of 28S ribosomal RNA at position 4324
[7]. The cleaved RNA is no longer capable of binding Elongation
Factor 2, which is needed for protein synthesis [8,9]. Once in the
target cell, a single ricin molecule can inactivate more than 1500
ribosomes per minute, ultimately resulting in cell death. The ricin
B chain binds to galactose-containing glycoproteins or glycolipids
on the surface of target cells and helps facilitate toxin entry into
cells via receptor-mediated endocytosis.
The levels of toxicity vary depending on the route of ricin
exposure. The mean lethal dose (LD50) in mice is approximately
1000–fold lower by injection or inhalation than by oral
administration [5]. The lethal dose for an adult human is about
0.35–0.7 mg by inhalation, whereas the lethal oral dose has been
estimated to be between 1 to 20 mg of ricin/kg body weight. The
large discrepancy in oral and systemic toxicity is likely due to the
harsh digestive conditions found in the stomach and epithelium
and innate immune barriers present in the intestinal tract [10].
Currently, there is no effective treatment available for ricin
intoxication. To develop methods for treatment of ricin intoxica-
tion, sensitive, accurate, and robust assay formats that can monitor
ricin in human biological samples in a timely manner are required
[11]. However, very small amounts of ricin are required to cause
lethality in small animals, and most existing methods for the
detection of ricin are not robust or sensitive enough for the
detection of ricin in biological samples such as sera or animal
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toxicokinetics of ricin and the dynamics of ricin following
intoxication. Previous attempts at determining the distribution
and fate of toxin employed radiolabelled ricin [12,13]. While the
location and intensity of radioactive label (either from intact or
degraded toxin) can be discerned, this method is not practical for
diagnostic uses in human biological samples.
Because of the high bioterrorism risk concern over ricin, more
and more recent research efforts have been directed to the design
of sensitive methods for the detection of this toxin in both buffer
and complex food matrices. They range from the common ELISA
techniques to quantitative PCR, multiplex detection, and even
mass spectrometry [11,14–20]. Several of these in vitro methods
allow the detection of ricin at concentrations as low as 50–100 pg/
ml. Recently, we developed a novel IPCR assay for ricin. This
assay combines the advantages of the flexible and robust
immunoassays with the exponential signal amplification power of
PCR [21]. It allows for the detection of as little as 10 fg/mL of
ricin in PBS buffer, 10 pg/mL in liquid egg and milk, and 100 pg/
mL in ground beef extracts. In this study, we applied the novel
IPCR assay to monitor the distribution dynamics of ricin after oral
or systemic intoxication, determine the biologic half-life of ricin in
sera, and evaluate the potential to use feces or sera as diagnostic
samples for ricin intoxication. The data obtained enriched our
knowledge of the process of ricin intoxication and the validated
IPCR assay provides a new diagnostic tool for the detection of
ricin in biological samples.
Materials and Methods
Materials
Pure ricin (RCA-II, Cat. # L1090) and polyclonal goat anti-
ricinus communis agglutinin I and II (Cat. # AS-2084) were
purchased from Vector Laboratories (Burlingame, CA) and stored
at 4uC. Soluble crude ricin extracts were prepared from castor
beans as described previously [14]. Briefly, castor beans, accession
PI215769, were obtained from USDA-GRIN, Southern Regional
Plant Introduction Station (Griffin, GA). Acetone powder was
prepared as described by Tewfik and Stumpf with slight
modification [22]. Dry seeds, with shells removed, were ground
in liquid nitrogen to a fine powder with mortar and pestle. Cold
acetone (5–10 mL/g powder) was then added to form a uniform
homogenate. The resulting mixture was filtered by suction on a
large Buchner funnel, washed 3 times with cold acetone, and 2
times with small portions of dry ethyl ether. The freshly prepared
powder was dried overnight in a vacuum desiccator over P2O5,
and stored at –20uC for future use. Crude ricin powder was
solubilized in phosphate-buffered saline (PBS: pH 7.3). The ricin
content of crude samples was estimated by SDS-PAGE followed
by Coomassie staining and densitometry comparison of unknown
RCA-II samples with a RCA-II protein standard curve (data not
shown). CD-1 mice (4.5-weeks old, female) were obtained from
Charles River Laboratories (Hollister, California).
Systemic and oral mouse models
Randomly grouped mice (weights of 18–20 g) were inoculated
intraperitoneally (ip) or intravenously (iv), via the lateral tail vein,
with 100 ml of toxin dosage sample; or orally, via gavage with a
popper feeding needle, with 100–200 mL of toxin dosage sample.
For the determination of mean lethal dose (LD50), groups of 10
mice were used at each dosage level and 4 or 5 dosage levels were
tested per experiment. Animals were monitored for at least 9 days
for signs of intoxication or death. Mice that were clearly moribund
were euthanized and counted as dead. LD50’s were calculated
using the Weil method [23]. Animal studies conducted herein,
adhere to institutional guidelines for husbandry approved by the
Animal Care and Use Committee of the U.S. Department of
Agriculture, Western Regional Research Center.
Histopathology of ricin intoxication in mice
Mice were dosed with lethal doses of pure or crude ricin via ip
or ig routes (0.006 mg of ricin by ip or 0.75 mg of ricin by ig).
Necropsy was performed on ricin treated or non-treated control
animals at indicated times (day 1 or 2). Organs (liver, pancreas,
kidneys, spleen, lymph nodes, heart, lung, brain, stomach, cecum,
small and large intestines, colon, and thymus) were preserved using
10% formalin and processed into paraffin blocks. 5 mm tissue
sections were then stained with hematoxylin and eosin. All samples
were blinded before histological pathology exams. Tissue process-
ing, embedding, sectioning, staining and analysis were performed
at the University of California Davis.
Serum toxicokinetic measurements
Blood was collected from mice (weights of 19.5–20 g) from the
submandibular site into serum collection tubes with gel separators
(BD Biosciences) at each time or dosage point. Samples were
incubated on ice for at least 30 min before centrifugation at 3000 g
for 10 min to isolate sera from the cellular fraction. Collected sera
were aliquoted and stored at 280uC before analysis. For the
mouse systemic toxicokinetic measurements, random groups of 5–
10 mice were injected iv via the lateral tail vein with 5 mg/mouse
of ricin holotoxin in phosphate saline buffer (PS: 10 mM
phosphate buffer, pH 7.8, 150 mM NaCl). In the oral model, 10
mice were treated with 1 mg ricin in 200 ml PS buffer via gavage
using round-ended Popper needles. Biological samples such as
urine and feces were collected by placing animals in metabolic
caging or in bedding-free caging with wire rack bottoms for
30 min prior to the indicated times. Standard curves and
unknowns were plotted and determined respectively using a
non-linear regression, with variable slope sigmoidal curve fitting
model provided by the GraphPad Prism statistics software.
Biologic half-life of ricin was determined by calculating two-phase
exponential decay over time (2.5 min to 480 min) using the same
program.
ELISA
ELISA was performed as described previously [21]. Briefly,
microtiter wells were coated with an anti-ricin mouse monoclonal
antibody mAb1642 at 4 mg/mL and incubated overnight at 4uC.
After blocking, 100 mL of toxin standards and samples were added
to each well and the plates were incubated at room temperature
(RT: 23–25uC) for 1 hour. After washing, 100 mL of goat anti-
ricin polyclonal antibody at 1 mg/mL was added to each well and
the plates were incubated for 1 hour at RT. The plates were then
washed with water and 100 mL of 1:20,000 diluted donkey-anti-
goat-HRP conjugate (Promega, Madison, WI) was added to each
well. After incubation for 1 hour at RT, the plates were washed
and 100 mL of Enhanced K-Blue substrate (Neogen Corp.,
Lexington, KY) was added to detect bound antibodies. The limit
of detection (LOD) is defined as the lowest concentration used for
the standard curve at which the average absorbance reading at
450 nm is higher than that of the negative control (NC) plus three
fold standard deviation (SD).
Immuno-PCR
IPCR was performed as described for Sandwich IPCR with
minor modifications [21]. Briefly, 30 mL of goat anti-ricin
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overnight at 4uC. After blocking non adsorbed sites with 150 mLo f
blocking buffer for 1 hour at RT, 30 mL of ricin standards or
samples were added to each well and the plates were incubated at
RT for 1 hour. The plates were washed, 30 mL of streptavidin-
conjugated goat anti-ricin polyclonal antibody (80 ng/mL) was
added to each well and incubated at 37uC for 30 min. After
washing, 30 mL of biotinylated DNA marker (0.5 ng/mL) was
added to each well and incubated at RT for 30 min. After
thorough washing to remove unbound DNA, the bound DNA was
detached from the immuno-complex by restriction enzyme
digestion with BamHI.A6mL digested aliquot was then used as
a template in real-time PCR (final 20 mL volume). It should be
noted that similar to other immunological assays, the sensitivity
and specificity of IPCR depend on the quality of the antibodies.
False positive results could be obtained when low specificity
antibodies are used.
PCR Data analysis
The cycle threshold (Ct) used was calculated automatically by
the instrument and represents the first PCR cycle at which the
fluorescent reporter signal exceeds the signal of a given uniform
‘threshold’ suggested by the instrument software. Duplicate
experiments were performed. Mean values and SD of Ct for the
intra-assay triplicate measurements of IPCR were calculated using
Microsoft Excel software. A linear regression fit of the data was
determined, along with 95% confidence limits, using the
GraphPad Prism 5.3 software (La Jolla, CA). The Ct value is
inversely proportional to the concentration of ricin. The lower the
ricin concentration is, the higher the Ct value will be. LOD of the
IPCR assay is defined as the lowest concentration used for the
standard curve at which its Ct value falls below the average Ct
value of the negative control minus 3 SD [24]. It is important to
note that the LOD is not absolute, but is calculated relative to the
value of the negative control. For the calculation of the LOD in
the sera and feces, these matrices were used for their calibration
curves. The assay recovery in sample matrices is calculated by
dividing the concentration quantified by the nominal concentra-
tion spiked into sample and then multiplying this value by 100.
Sample preparation
Serum calibration curves were prepared by spiking 10 ml of 10-
fold serial dilutions of ricin in 90 ml of sera samples; the samples
were then diluted at a 1:9 ratio in PBS to remove any matrix effect
before IPCR analysis. Feces standard curves were prepared by
spiking 10-fold serial dilutions of ricin in PBS to feces pellets (1 g of
feces in 10 mL PBS). The samples were homogenized, and then
centrifuged for 5 min at 10,000 g. The supernatants were diluted
at a 1:9 ratio in PBS and used for IPCR analysis.
Polyclonal antibody neutralization of ricin intoxication
Random groups of 5 or more mice were treated iv with 5 mg/
mouse of ricin in PS buffer. 100 mg of polyclonal goat anti-ricin
antibodies diluted in PBS buffer were introduced iv at 30 min
prior to toxin or at indicated time intervals post-intoxication. For
neutralization of ricin following oral intoxication, random groups
of 10 mice were treated with 1 mg ricin (200 ml of 5 mg/ml toxin
stock solution) via gavage. 80 mg of goat anti-RCA I and II was
diluted in PBS and injected iv either prior to or after intoxication
at indicated times. All mice were monitored for at least 12 days for
symptoms of intoxication, weight gain/loss or death. Statistical
significance was determined using Log rank tests of survival curves
using the GraphPad Prism statistics software where p,0.05.
Results
In vivo toxicity of ricin
The in vivo toxicity of pure ricin was determined for both
systemic (via ip or iv intoxications) or oral routes of intoxication in
adult CD-1 outbred mice (Table 1). Toxicity was expressed as
mean lethal dose (LD50) values. The lower the units (mg ricin/kg),
the higher the toxicity, as less toxin was required for lethality. In
this study, the mouse LD50 for pure ricin in the oral or intragastric
(ig), intraperitoneal (ip) and intravenous (iv) routes of intoxication
were 29 mg/kg, 0.023 mg/kg and 0.008 mg/kg respectively.
Histopathology of ricin intoxication
Mice were dosed ip with 0.006 mg, or about 13 LD50 units of
ricin per mouse. Lethality was observed between days 2–4 after
intoxication. Necropsies were performed on day one when animals
were ruffled and slow in motion, and on day two on moribund
mice. On day one post-intoxication, tissue sections revealed mild
lymphoid reactivity as characterized by the presence of tingible
body macrophages in the mesenteric lymph nodes (Fig. 1A) and
spleen. Mild pancreatic necrosis was also present. On day two
post-intoxication, severe to moderate lymphoid necrosis was
observed in the thymus, spleen and lymph nodes (Fig 1B). Other
organs or tissues had no significant changes compared to untreated
mice (Fig. 1C). Moderate epithelial acinar necrosis in the pancreas
was also observed. Orally treated mice showed similar lymphoid
reactivity and necrosis in the lymph nodes, spleen and thymus as ip
treated mice (data not shown). In several mice, gastric necrosis or
acute enteritis was also observed.
IPCR detection of ricin in biological samples
Our previous results showed that a sandwich IPCR improved
ricin detection sensitivity 10- to 1,000-fold in spiked ground beef,
milk and chicken eggs when compared to an analogous ELISA
assay [21]. In this study, we evaluated the same IPCR protocol on
sera and feces samples from mice. Sera and feces were collected
from healthy mice. Processed samples were spiked with ricin
before a 10-fold serial dilution. Three replicate IPCR measure-
ments were carried out for each serial dilution of ricin
(concentration range: 0.1 to 100,000 pg/mL) plus an un-spiked
blank or negative control. Figure 2 shows the average cycle
threshold (Ct) values obtained by IPCR versus the log of the
concentration of ricin for three replicate measurements of ricin in
sera (A) and feces (B). The limit of detection (LOD) for sera and
feces using this assay is 1 pg/mL based on the linear regression
and 95% confidence limits derived from the sample data. The log
linear quantification range of the assay is 1 to 10,000 pg/mL. A
qualitative detection of ricin in sera lower than 1 pg/mL is also
possible due to a clear separation of the signals at 0.1 pg/mL (Ct
value 6 SD =28.5060.24) from the negative control (Ct 6 SD
=30.7960.19). Table 2 shows the recovery of ricin from spiked
mouse sera and feces samples. At ricin levels ranging from 1–
Table 1. LD50 of pure ricin in mouse toxicity tests.





aRicin holotoxin content 6 SEM.
doi:10.1371/journal.pone.0012858.t001
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recovery from feces was at least 89.7%.
The detection sensitivities of the IPCR assays for ricin in mouse
sera and feces were compared with a standard ELISA method
(Table 3). The detection threshold for ricin in mouse sera and feces
by sandwich ELISA was about 10 ng/mL; about 4 orders of
magnitude less than the 1 pg/mL sensitivity of the IPCR method.
Figure 1. Sections of lymph nodes in mice ip treated with pure
ricin were stained with hematoxylin and eosin. A. Lymph node at
day one post-intoxication. Several tingible body macrophages (arrows)
are present within a follicle consistent with lymphoid reactivity. B.
Lymph node at day two post-intoxication. There is moderate lymphoid
necrosis characterized by clusters of small, dark basophilic, round
apoptotic bodies (arrows) admixed with intact lymphocytes. C. Lymph
node from non-treated control mouse for comparison. Bar=100 mm.
doi:10.1371/journal.pone.0012858.g001
Figure 2. Standard curves for IPCR detection of ricin in sera
and feces. Ct values were plotted against log ricin concentrations (pg/
mL) for three replicate samples in mouse sera (A) and feces (B). The
linear regression of the calibration curve has a correlation coefficient of
r
2=0.99. The dashed lines are the upper and lower 95% confidence
limits. The solid horizontal thick line denotes the average blank Ct
value, with the standard deviation drawn at each end of this line. The
solid horizontal thin line intersecting the linear regression line indicates
the detection threshold of the IPCR assay as defined in the text.
doi:10.1371/journal.pone.0012858.g002
Table 2. Percent (%) recovery of ricin from mouse sera and
feces.
Spike level
(pg/mL) 1 10 100 1,000 10,000
Serum 98.460.9 103.462.4 107.160.8 109.460.9 98.260.1
Feces 101.260.2 112.460.3 99.760.8 89.960.9 89.762.0
Data is the average of three replicates 6 one standard deviation.
doi:10.1371/journal.pone.0012858.t002
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intoxication, mouse feces were collected after oral inoculation of
increasing doses of ricin over time (Table 4). The presence of ricin
was determined by IPCR. Feces from mice that did not receive
ricin treatment were used as negative controls. Samples with
average Ct values of three replicate measurements below that of
the negative controls minus 3 standard deviations were considered
as ricin positive. Ricin can be detected in feces of mice fed at least
10 mg of ricin per mouse, a non-lethal dose. At higher doses (up
to1 mg/mouse), the presence of ricin was clearly found in feces
deposited within the first 2 hours after intoxication, while at lower
doses (400 mg/mouse or less), ricin was detected frequently in feces
deposited after 2 hours post intoxication. In addition, ricin was still
detectable in feces deposited between 6 and 24 hours post
inoculation at doses of 400 mg/mouse and 1 mg/mouse.
Systemic ricin intoxication
Ricin toxin toxicokinetics data is needed to understand the
biological activity of natural ricin. In vivo data from mice have been
difficult to obtain due to the lack of sensitive methods for the
detection of minute quantities of ricin in the complex matrices of
biological samples. Our new IPCR method is an amenable system
for testing biological samples. To determine the toxicokinetics of
ricin following systemic intoxication, we applied this IPCR method
to analyze collected sample sets of at least 5 mice challenged iv
with a 5 mg/mouse dose or about 33 mouse LD50’s of ricin. Sera
were collected from each set of mice over time and the
concentration of ricin at each time point was determined from a
standard curve used in the IPCR. Figure 3A shows a graph of sera
concentrations of ricin plotted over time. The first 30 min were re-
plotted on a Fig. 3B for a closer look of the early time points. A
sharp drop in blood ricin levels was observed within the first
10 min of toxin introduction. This initial phase or alpha half-life
(t1/2a) was determined to be 4 min (Fig 3B). A slower phase or
beta half-life (t1/2b), was determined to be approximately 86 min.
Free toxin in sera could potentially be neutralized and cleared
by anti-toxin antibodies. In previous work, serum toxicokinetics of
the botulinum neurotoxin (BoNT) serotype A were compared in
parallel with antibody neutralization of toxin [25]. Decreasing
levels of BoNT/A present in sera over time (i.e.: increased
absorption of toxin) correlated directly with a decrease in antibody
neutralization when anti-BoNT/A antibodies were introduced at
subsequently longer times post-intoxication. Thus antibody
neutralization assays could help predict the presence of toxins
available in sera.
Using a similar antibody neutralization assay, neutralization of
ricin in sera was successfully achieved using a goat polyclonal
antibody to ricin. Mice treated iv with 100 mg of antibodies
30 min prior to intoxication with 5 mg of ricin by iv were
completely protected from death (Fig. 4A). Addition of the same
concentration of antibodies to ricin-treated mice at 2, 5 and
10 min after intoxication conferred some degree of protection as
shown by the increase of time-to-death but failed to rescue mice
from death. Mice treated at 2 min with antibodies survived the
longest with a median survival time of 46 h, followed by median
survival times of 37 h and 26 h for mice treated with antibodies at
5 and 10 min respectively. Mice treated with antibodies at 15 min
or later (data not shown) showed similar time-to-death curves as
the no antibody (PBS only) negative control, which had median
survival times of 13 h. A log rank test comparison of survival
curves showed statistically significant differences (p,0.0001).
Oral ricin intoxication
The oral intoxication mouse model was used to assess the transit
time of ricin from the stomach to the bloodstream. Mice were
treated orally with 1 mg or about 1.7 LD50 of ricin. The time-to-
death for mice treated post-intoxication with control PBS varied
from 50 h to 170 h (Fig 4B) with a median survival time of 110 h.
Because the transit time varied greatly among animals and the
blood clearance rate of ricin can be very rapid as shown in the
Table 3. Detection of ricin in mouse sera and feces using
IPCR and sandwich ELISA.
Spike
level IPCR (average Ct ± s.d.) ELISA (average A450 ± s.d.)
ng/mL Serum Feces Serum Feces
0 30.7960.19 30.0260.03 0.1460.01 0.1460.01
0.001 28.3760.14 28.9060.67 n/a n/a
0.01 27.3160.09 27.9260.50 n/a n/a
0.1 26.3960.15 26.6660.56 0.1460.01 0.1460.01
1 24.9160.02 25.5260.92 0.1760.01 0.1560.01
10 24.0860.04 23.3461.00 0.4760.01 0.2760.01
100 n/a n/a 1.0860.01 0.9660.01
1,000 n/a n/a 1.1260.03 1.5160.04
Data is the average Ct value and absorbance reading at 450 nm of three
replicates 6 one standard deviation (s.d) from IPCR and ELISA. n/a, not
applicable.
doi:10.1371/journal.pone.0012858.t003
Table 4. Detection of ricin in mouse feces after oral administration using an IPCR assay.
Hours after oral
administration
Amount of ricin fed (mg/mouse) Control 0–2 h 2–4 h 4–6 h 6–24 h
1 0/5 1/5 1/5 1/5 ND
10 0/5 0/5 4/5 4/5 ND
100 0/3 1/3 3/3 3/3 0/3
200 0/3 1/3 3/3 3/3 0/3
400 0/3 1/3 3/3 3/3 3/3
1000 0/7 6/7 6/7 6/7 6/7
Data indicates the numbers of mice determined by IPCR as ricin positive in feces versus the numbers of mice tested. ND, not determined.
doi:10.1371/journal.pone.0012858.t004
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consistent data from sampling of mouse sera alone. Far too many
mice would be required to obtain enough statistically significant
data from close time points. We therefore used an oral antibody
neutralization assay to estimate the time it took ricin to traffic from
the intestinal tract to the blood stream. Ricin that crossed the
intestinal barrier into the bloodstream would be absorbed and
distributed quickly, and only when enough neutralizing antibodies
against ricin are present prior to arrival of ricin may mouse
survival or increased survival time occur.
No deaths occurred when intoxicated mice were treated with
80 mg of polyclonal goat anti-ricin antibodies by 6 h post-
intoxication (Fig. 4B) but about 30% lethality were observed
when antibodies were applied at 7 h post-intoxication. Increasing
the time interval between intoxication and rescue such as adding
antibodies at 8 h or later post-intoxication increased the mortality
rates.
Discussion
Ricin, one of the most potent biological toxins and U.S.
government listed Select Agents, is a serious bioterrorism concern.
The toxin can potentially be delivered via inhalation (in), oral or
systemic routes of intoxication. Data for human intoxication have
been scarce [3,5]. Using the mouse as a model for intoxication, we
determined the LD50 of pure ricin to be 29 mg/kg when
administered orally, compared to 0.023 mg/kg for the LD50
observed when administered ip (Table 1). The oral LD50 was
approximately 1200 times higher than ip-treated mice, consistent
with previous data [3,26,27]. Even less ricin, 0.008 mg/kg, or
about 3600 times less toxin, is required to cause lethality in mice
when introduced iv. The differences in toxicity of the different
routes illustrate the differences in how the toxin is absorbed and
processed in vivo. Gastric secretions, the intestinal epithelia and
mucosal immunity may present strong barriers to ricin absorption
and distribution as indicated by the relatively large doses of ricin
needed to cause death upon oral intoxication [10]. Ricin is much
more readily absorbed when introduced via any of the other three
routes of intoxication (in, ip or iv) where close proximity to the
bloodstream and more accessible cells are thought to be available
[3].
Despite large differences in LD50 values, a comparison of the
histopathology of mouse organs or tissues showed that ip and
orally intoxicated mice displayed similar lesions in lymphoid
tissues (Fig. 1 and data not shown). Occasional intestinal epithelial
or mucosal damage was observed in orally treated animals as
manifestation of route specific damage. The susceptibility to ricin
toxicity may also vary depending on the animal host. In studies
using the rat, lesions were observed in the liver or kidneys, whereas
no such detectable lesions were observed in the same organs in
mice [3,28]. This may be partly due to the presence of different
cell receptors of different animal species capable of binding ricin
[29].
Figure 3. Serum toxicokinetics of ricin. A. Concentrations of ricin in
mouse sera over 480 min post -intoxication. Ricin content was
determined by IPCR. B. Concentrations of ricin in mouse sera from 2
to 30 min post-intoxication illustrating early and rapid sequestration of
ricin with a t1/2a half-life of 4 min. Each point in the graph represents
the mean value 6 SEM. N$5.
doi:10.1371/journal.pone.0012858.g003
Figure 4. Neutralization of ricin with polyclonal ricin antibod-
ies. Survival percentage of mice dosed iv (A) or ig (B) with ricin were
plotted over 160 h post-intoxication. Goat anti-ricin antibodies were
introduced iv either prior-to or post-intoxication at indicated times. PBS
was injected into mice as no treatment control. Comparison of survival
curves with log rank test yielded statistical significance of p,0.001 and
p,0.0144 for A and B respectively.
doi:10.1371/journal.pone.0012858.g004
Toxicokinetics of Ricin
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ricin extracts, as it is likely that crudely prepared ricin could be
used in either intentional or unintentional intoxications. Crude
ricin extracts contain many other proteins such as the less toxic
agglutinin or RCA-I and other superantigens [30]. However,
under our experimental conditions, oral and ip toxicities of pure
and crude ricin were similar when adjusted for ricin content and
no discernible differences in histopathology were observed
(unpublished data). Presumably, the lethality observed and visible
signs of lesion are caused mainly by ricin.
Because of the high potency of ricin, very little toxin is required
to cause illness. The small amount present in animal biological
samples, such as sera and bodily wastes, makes diagnosis of
intoxication difficult. We tested a new IPCR assay for use as a new
diagnostic tool for ricin. Mouse intoxication models were used in
an effort to simulate the detection of ricin in human biological
samples. Sera and feces from mice treated with known quantities
of ricin were processed and the concentration of ricin in samples
was determined using both IPCR and traditional ELISA assays.
Table 3 showed that the detection threshold for ricin in serum and
feces was 1 pg/mL by IPCR, and 10 ng/mL by ELISA; the IPCR
assay was therefore 10,000-fold more sensitive than its comparable
ELISA assay. The concentration of ricin in feces varied from
animal to animal but the general trend showed initial appearance
of ricin at about 2 hr post inoculation (hpi), peaking at
approximately 6 hpi (Table 4). After 24 hpi, we could not detect
the ricin in feces in mice dosed with 200 mg/mouse or less. Mice
dosed with 400 mg/mouse or more were mildly positive for
presence of ricin in feces at 24 hpi. No ricin was detected in the
feces of mice dosed intravenously. Thus, it is possible to detect
ricin in feces samples from mice treated with sub-lethal amounts of
ricin hours to a day after ingestion.
The high sensitivity of the IPCR assay allowed the evaluation of
the toxicokinetic behavior of ricin following systemic intoxication
in mice. The toxicokinetics of ricin in mouse sera was shown to be
biphasic (Fig 3). The early phase or alpha half-life (t1/2a) was
determined to be 4 min (Fig 3A). This phase of rapid toxin decline
likely represents the quick distribution and absorption of toxin by
tissues. A slower decline phase or beta half-life (t1/2b) follows the
t1/2a; this phase was determined to be about 83 min (Fig 3B). The
t1/2b likely represents clearance of excess toxin from the blood,
likely when tissues have absorbed as much ricin as possible; excess
toxin is cleared slowly from the blood stream by metabolism or via
unknown mechanisms [3,31]. Following extrapolation of the sera
data, about 2.3 mg of ricin was detected in sera at time 0 (Fig. 3A).
This constitutes about 50% of the injected ricin and is consistent
with recovery amounts detected by others. The rest of ricin is
thought to be associated with cells and thus not detectable in the
sera [12,13]. Previous attempts to determine ricin toxicokinetics in
mice using ELISA methods only showed a linear degradation over
4 h [12,13]. No early times (before 1 h) were measured, so the t1/
2a was likely not observed. However, we believe the differences in
detection methodology, starting concentrations of toxin and timing
of samplings, could have contributed to the differences in
toxicokinetic measurements. Our detailed measurement of ricin
content in sera at early time points post-intoxication revealed a
more complete picture of toxin toxicokinetics.
A wide range of time-to-deaths was observed in mice orally
dosed with 1 mg of ricin (Fig. 4B – PBS). This suggested a wide
time frame in which ricin could be absorbed by mice and thus the
difficulty in accurately detecting systemic ricin following oral
intoxication. The absorption rate of ricin would depend on the
individual animal, toxin clearance or degradation by gastric
secretions in the intestinal tract, or natural susceptibility of the
animal. Toxin may also be absorbed differently depending on the
amount or quality of food remaining in an animal’s stomach, as
extra food components such as certain sugars may inhibit toxin
absorption [32].
To estimate the time period when ricin molecules travel from
the intestinal tract to the blood stream, we performed an antibody
neutralization assay for mice dosed orally with a lethal dose of
ricin. Antibody neutralization assays have been applied previously
to mice dosed with BoNT [25]. Decrease of toxin in sera over time
matched the decrease in antibody neutralization potential of anti-
toxin monoclonal antibodies administered at subsequently later
times post-intoxication. In this study, a similar neutralization assay
was performed with iv ricin-intoxicated mice. Complete protection
was observed when polyclonal antibodies against ricin were
administered 30 min prior to ricin administration (Fig 4A)
showing clearly that when enough antibodies are in place in the
mouse, complete clearance of toxin occurs. Decreased protection
was observed when antibodies were applied post-ricin, even as
early as 2 min post-intoxication. Incomplete rescue of mice from
death correlated well with the ricin serum toxicokinetic data,
which showed that ricin was sequestered from the bloodstream at
at 1/2a of 4 min (Fig. 3). Increased delay of antibody administra-
tion after ricin introduction led to a faster time-to-deaths,
suggesting that more ricin was absorbed preventing neutralization
by antibodies. Thus an antibody protection assay can give a
reasonable estimation of serum transit for toxins.
Orally intoxicated mice were assessed similarly using this
antibody neutralization assay. Intoxicated mice were protected
from death when antibodies were introduced up to 6 h post-
intoxication (Fig. 4B), suggesting that it took at least 6 h to traffic
significant amount of ricin from the mouse stomach to the
bloodstream. Some lethality was observed when antibodies were
added at 7 h post-intoxication, indicating that for some mice,
enough ricin reached the bloodstream and was absorbed into
tissues between 6 and 7 h post intoxication, before antibody
administration. Increasing the time between ricin challenge and
antibody administration decreased the percentage of survival.
Most ricin ingested from the oral route would be degraded in
the intestinal tract or shed as waste. Ricin distribution in organs
was previously determined by localization of radiolabelled toxins
[12,13]. Most ricin was found in the liver, spleen and the adrenal
cortex of mice following iv intoxication. However, no histopathol-
ogy has been observed in the liver where most ricin is found. It is
likely that the liver served to quickly metabolize ricin and
contributed to the quick elimination of toxin from sera.
Ricin is not detected in urine, as most large protein molecules
are usually filtered by the kidneys prior to urine production.
Instead, a less toxic alkaloid ricinine, present in crude castor
preparations [33], is secreted with urine and can be detected in the
urine or gastric secretions by mass spectrometry techniques [29].
Currently, ricinine is used as a surrogate marker for ricin
intoxication and diagnostic tests for it are available for use in
animal and human samples.
This study validated the use of a novel IPCR method in the
detection of ricin in mouse sera and feces, providing a framework
for future diagnostic use of this assay in real human biological
samples. Improvements on the toxicokinetics measurements and
the determination of pathological effects of ricin following systemic
and oral intoxication will provide a better understanding of the
etiology of intoxication. The data obtained here will help in the
future design of more effective diagnostics and therapeutic
methods for ricin poisoning. In addition, we believe the methods
developed herein could also be adapted for use as new diagnostic
and research tools for other protein toxins as well.
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